Can Chemotherapy Cause Tremor as a Side Effect?

Chemotherapy can be associated with tremor in certain situations, although it is not among the most common side effects for most regimens. ^[1] Some cancer drugs (for example, high‑dose cytarabine) can cause neurological changes including intention tremor and coordination problems when reaching or performing movements. ^[2] Tremor may also appear indirectly due to drug‑induced neuropathy, metabolic changes, steroid use, or paraneoplastic neurological syndromes. ^[3] [PM10]

---

How Chemotherapy Can Lead to Tremor

• Direct neurotoxicity from specific agents
  High‑dose cytarabine can cause cerebellar toxicity, leading to ataxia (unsteady gait), dysarthria (slurred speech), nystagmus, and intention tremor during voluntary movement. ^[2] These symptoms often emerge during treatment, especially in older adults or those with renal impairment. ^[4]

• Peripheral neuropathy and motor symptoms
  Several classes of anticancer drugs can injure peripheral nerves, typically causing numbness, tingling, and sensory loss in a “glove and stocking” pattern; in more severe cases, motor involvement may contribute to shakiness or impaired fine motor control that can be perceived as tremor. ^[3] Platinum agents like cisplatin are dose‑related and may worsen for months after stopping therapy (“coasting”). ^[5]

• Acute neuro‑excitability syndromes
  Oxaliplatin can cause acute neurotoxicity, including muscle hyperexcitability and abnormal sensations; case experience suggests agents like pregabalin may help in some patients. [PM18] Oxaliplatin neurotoxicity includes both acute cold‑triggered symptoms and chronic neuropathy. [PM19]

• Drug‑induced tremor from non‑oncology co‑medications
  Tremor can be triggered by various medications, including certain cancer drugs (e.g., thalidomide, cytarabine), bronchodilators, immunosuppressants, and mood stabilizers; reviewing all current medicines is important. ^[1] Medication‑related tremor typically occurs with action or posture and improves when the triggering drug is reduced or stopped. ^[6]

• Paraneoplastic neurological syndromes (immune‑mediated)
  Some cancers can trigger autoantibodies (e.g., anti‑Hu), leading to neurological signs such as intention tremor, balance issues, and speech changes; management focuses on treating the underlying cancer and immune modulation. [PM10]

---

Warning Signs That Need Prompt Attention

• New coordination problems or intention tremor, especially with cytarabine or regimens known for neurotoxicity. ^[2]
• Slurred speech, nystagmus, handwriting deterioration, or inability to perform rapid alternating movements, which suggest cerebellar involvement. ^[2]
• Rapidly worsening gait or falls, which are reported signs of neurotoxicity and require urgent assessment. ^[7]
• Sensory loss, numbness, or tingling progressing to the hands/feet, consistent with chemotherapy‑induced neuropathy. ^[3]
• Symptoms that persist or worsen between cycles (coasting) after platinum therapy. ^[5]

If any of these occur, clinicians generally reassess, consider dose reduction, delay, or discontinuation, and evaluate for reversible contributors (renal function, drug interactions). ^[4]

---

Practical Coping Strategies

• Report symptoms early
  Ongoing neurological assessments during neurotoxic treatments help detect problems sooner, allowing dose adjustments or pauses to prevent progression. ^[4]

• Medication review
  A careful review of all prescriptions and over‑the‑counter drugs can identify tremor‑provoking agents; adjusting or substituting them may improve tremor. [PM8] Medication review is considered essential when tremor may be drug‑induced. [PM7]

• Manage neuropathy contributors
  For chemotherapy‑induced peripheral neuropathy, strategies include dose modification and symptomatic treatments; early identification may prevent long‑term deficits. ^[3] Platinum‑related symptoms may continue for months, so safety planning and monitoring are important. ^[5]

• Address oxaliplatin‑specific triggers
  For oxaliplatin acute neurotoxicity, avoiding cold exposure (cold drinks, cold weather) can reduce symptoms between cycles; symptoms often improve during treatment breaks. ^[8] Cold sensitivity typically gets better between treatments but may last longer with more cycles. ^[9]

• Rehabilitation and assistive strategies
  Occupational and physical therapy can help with fine motor tasks, balance training, and fall prevention, which are valuable when tremor coexists with ataxia or neuropathy. [PM8] Non‑drug approaches (e.g., adaptive utensils, wrist weights) may aid daily tasks in tremor management. [PM7]

• Pharmacologic options for tremor (when appropriate)
  If tremor resembles essential tremor, beta‑blockers like propranolol or primidone may be considered, balancing side effects and interactions. [PM8] For resistant limb or voice tremors, botulinum toxin can be useful, acknowledging the risk of weakness. [PM11] For parkinsonian tremor, dopaminergic agents can help in selected cases, but this requires specialist evaluation and careful consideration of oncology interactions. [PM7]

---

When to See a Specialist

• Suspected cerebellar toxicity (e.g., with cytarabine) warrants urgent neurological examination and treatment reassessment. ^{[2] [4]}
• Progressive or disabling tremor despite basic measures should prompt referral to neurology to clarify tremor type (rest, action, intention) and tailor therapy. [PM8]
• Features suggesting paraneoplastic syndrome (multi‑system neurological signs, rapid onset) merit coordinated care with oncology and neurology and consideration of immune‑modulating therapies. [PM10]

---

Key Takeaways

• Yes, chemotherapy can be linked to tremor, most notably through cerebellar toxicity with agents like high‑dose cytarabine, through neuropathy from multiple drug classes, or via medication‑induced tremor and paraneoplastic processes. ^{[2] [3] [1]} [PM10]
• Early reporting and assessment help prevent progression; clinicians may adjust doses or delay treatment when neurotoxicity is suspected. ^[4]
• Management blends prevention, medication review, symptom‑targeted therapies, rehabilitation, and, when indicated, specialist treatments such as botulinum toxin or tailored tremor medications. [PM7] [PM8] [PM11]

---

궁금한 점 있으면 언제든 퍼슬리에 물어보세요.